Trial Profile
Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation – a double‐blind, randomized, placebo‐controlled, study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2019
Price :
$35
*
At a glance
- Drugs Renzapride (Primary)
- Indications Irritable bowel syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Alizyme
- 16 Feb 2010 Results published in Alimentary Pharmacology and Therapeutics.
- 23 Apr 2008 Due to the limited efficacy of renzapride demonstrated in this trial further development of renzapride is being discontinued as reported by Alizyme.
- 22 Jan 2008 The expected completion date for this trial is now 1 Feb 2008.